What Treatments Are Effective for Chronic Nausea and Vomiting?

Gastric electrical stimulation reduces vomiting in patients with refractory chronic vomiting and/or nausea, researchers report in a randomized trial published in the February issue of Gastroenterology. Chronic nausea and vomiting are estimated to affect 2.2% of the adult population. For many patients, dietary changes and medical treatments do not improve symptoms,

Read more
  • What Comes First — the Psychological Disorder or the Gastrointestinal Disorder?

What Comes First — the Psychological Disorder or the Gastrointestinal Disorder?

More patients receive a diagnosis of a mood or anxiety disorder before diagnosis of a functional gastrointestinal disorder (FGID), researchers report in the July issue of Clinical Gastroenterology and Hepatology. The findings indicate opportunities for prevention and support the role of adverse socioeconomic factors in development of FGIDs in patients

Read more
  • What are Choledochoceles?

What are Choledochoceles?

Choledochoceles are cystic dilatations of the intraduodenal portion of the common bile duct. They are often classified as Type III biliary cysts, but have distinct demographic and anatomic features, and a lower risk of malignancy than other types of choledochal cysts. In the February issue of Clinical Gastroenterology and Hepatology,

Read more

What are the Complications of Weight Loss Surgery?

Bariatric surgery is effective treatment for obesity and its related disorders. Yet as increasing numbers of patients undergo this procedure, gastroenterologists encounter a growing number of complications. A Perspective article in the April issue of Clinical Gastroenterology and Hepatology discusses common complications of bariatric surgery and ways to manage them. Bariatric

Read more

A Rare, Autoimmune Cause of Intractable Nausea and Vomiting

Some cases of unexplained, intractable vomiting are caused by an autoimmune disorder in which patients develop antibodies against the brain protein astrocytic aquaporin-4 (AQP4), according to the March issue of Clinical Gastroenterology and Hepatology. AQP4 is a water channel in the central nervous system. Antibodies against AQP4 cause neuromyelitis optica

Read more

New Treatment for IBS

LX1031, a drug that inhibits serotonin production, relieves symptoms and increases stool consistency in patients with nonconstipating irritable bowel syndrome (IBS), according to a study by Philip Brown et al. in the August issue of Gastroenterology. Serotonin (also called 5-hydroxytryptamine or 5-HT) is a neurotransmitter that controls mood and cognition, as

Read more